Kemula Pierre Thadee Victor
SEC insider (Form 3/4/5 filer). CIK 0002119332. Chief Financial Officer at AgomAb Therapeutics NV (AGMB). 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in ANTWERPEN.
Companies Kemula Pierre Thadee Victor has filed insider reports for
- AgomAb Therapeutics NV (AGMB): Officer, Chief Financial Officer
Kemula Pierre Thadee Victor
CIK: 0002119332
Transaction Breakdown
Open Market Buys (P)3 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AGMB
AgomAb Therapeutics NV
Officer